Intensive Sequential Dose Dense Chemotherapy With Stem Cell Support as First-Line Treatment in Advanced Ovarian Carcinoma: A Phase II Study

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gemcitabine Plus Vinorelbine as First-Line Chemotherapy in Advanced Nonsmall Cell Lung Carcinoma a Phase II Trial

Cancer
Cancer ResearchOncology
2000English

IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma With Bronchioloalveolar Carcinoma Subtype

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Analysis of 96 Patients With Advanced Ovarian Carcinoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2004English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Preoperative High-Dose Chemotherapy With Peripheral Blood Stem Cell Support as a Primary Management of Locally Advanced Breast Cancer

Bone Marrow Transplantation
TransplantationHematology
2001English

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

Optimal First‐line Treatment for Advanced Thymic Carcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy